IFNA1 and neoplasm: Therefore, we hypothesized that the sustained IFN responses in the TME of EBV DNA Sero+ NPC render tumor-driven adaptive immunity resistant, enhance the immunosuppressive capacity of tumor cells, and ultimately lead to malignant transformation and therapeutic resistance.